Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resecti Published Date December 15, 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen